By Admin at 18 Jan 2016
Right now, researchers must use billions of T cells in adoptive cell therapy. However, a new “intelligent biogel” may change that, such that only millions of T cells would be required. Plus, the biogel shows promise in revolutionizing many cancer treatments.
58
Current Gateway-funded clinical trials
150+
Clinical trials funded at leading institutions worldwide
$16.56
Funds one patient for one day at a Gateway-funded clinical trial
